UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

BMC cancer, 2007-07, Vol.7 (1), p.134-134, Article 134

2007

Link zum Volltext

Verfügbarkeit prüfen

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer

Nature communications, 2016-07, Vol.7 (1), p.12156-12156, Article 12156

2016

Link zum Volltext

Verfügbarkeit prüfen

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

PLoS medicine, 2010-05, Vol.7 (5), p.e1000279-e1000279

2010

Link zum Volltext

Verfügbarkeit prüfen

The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/ glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (3), p.830-835

2004

Link zum Volltext

Verfügbarkeit prüfen

PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer

Cancer research (Chicago, Ill.), 2012-03, Vol.72 (6), p.1529-1537

2012

Link zum Volltext

Verfügbarkeit prüfen

PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers

Cancer research (Chicago, Ill.), 2016-06, Vol.76 (11), p.3130-3135

2016

Link zum Volltext

Verfügbarkeit prüfen

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer

European journal of cancer (1990), 2013-07, Vol.49 (10), p.2441-2448

2013

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort

BJU international, 2014-12, Vol.114 (6b), p.E99-E104

2014

Link zum Volltext

Verfügbarkeit prüfen

Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with CD9 mRNA Modifications

Clinical cancer research, 2007-04, Vol.13 (8), p.2354-2361

2007

Link zum Volltext

Verfügbarkeit prüfen

Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance

Cancer, 2008-07, Vol.113 (2), p.286-292

2008

Link zum Volltext

Verfügbarkeit prüfen

Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant

Human pathology, 2015-10, Vol.46 (10), p.1506-1513

2015

Link zum Volltext

Verfügbarkeit prüfen

New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model

Arthritis research & therapy, 2010-01, Vol.12 (3), p.R124-R124

2010

Link zum Volltext

Verfügbarkeit prüfen

ERG Protein Expression and Gene Rearrangements Are Present at Lower Rates in Metastatic and Locally Advanced Castration-resistant Prostate Cancer Compared to Localized Disease

Urology (Ridgewood, N.J.), 2013-08, Vol.82 (2), p.394-399

2013

Link zum Volltext

Verfügbarkeit prüfen

A 20-Year-Old-Man With New Onset of Melena

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.e14-e15

2022

Link zum Volltext

Verfügbarkeit prüfen

Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy

Human pathology, 2014-10, Vol.45 (10), p.2006-2013

2014

Link zum Volltext

Verfügbarkeit prüfen

Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma

The journal of pathology. Clinical research, 2018-07, Vol.4 (3), p.167-174

2018

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite Instability in Benign and Malignant Thyroid Neoplasms

The Journal of surgical research, 2008-11, Vol.150 (1), p.40-48

2008

Link zum Volltext

Verfügbarkeit prüfen

Familial prostate cancer: the damage done and lessons learnt

Nature reviews. Urology, 2013-02, Vol.10 (2), p.116

2013

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

JNCI : Journal of the National Cancer Institute, 2003-10, Vol.95 (19), p.1482-1485

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers

Cancer research (Chicago, Ill.), 2002-12, Vol.62 (23), p.6808-6811

2002

Link zum Volltext

Verfügbarkeit prüfen

Expression and Nuclear Localization of ErbB3 in Prostate Cancer

Clinical cancer research, 2006-05, Vol.12 (9), p.2730-2737

2006

Link zum Volltext

Verfügbarkeit prüfen

Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer

Clinical cancer research, 2005-06, Vol.11 (11), p.4003-4011

2005

Link zum Volltext

Verfügbarkeit prüfen

Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer

BJU international, 2007-08, Vol.100 (2), p.303-309

2007

Link zum Volltext

Verfügbarkeit prüfen

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer

Urology (Ridgewood, N.J.), 2002-05, Vol.59 (5), p.652-656

2002

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

Clinical cancer research, 2004-12, Vol.10 (24), p.8460-8464

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/ glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer

PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer

Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort

Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with CD9 mRNA Modifications

Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance

Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant

New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model

ERG Protein Expression and Gene Rearrangements Are Present at Lower Rates in Metastatic and Locally Advanced Castration-resistant Prostate Cancer Compared to Localized Disease

A 20-Year-Old-Man With New Onset of Melena

Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy

Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma

Microsatellite Instability in Benign and Malignant Thyroid Neoplasms

Familial prostate cancer: the damage done and lessons learnt

Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers

Expression and Nuclear Localization of ErbB3 in Prostate Cancer

Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer

Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer

Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

Suchergebnisse filtern